| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 288.951 | 301.899 | 304.119 | 214.642 | 16.787 | 16.229 | 16.700 | 16.798 | 17.803 | 19.802 |
| Total Income - EUR | 295.248 | 304.628 | 306.761 | 629.845 | 16.794 | 16.268 | 16.703 | 16.798 | 17.914 | 19.805 |
| Total Expenses - EUR | 283.733 | 282.400 | 287.920 | 221.922 | 9.731 | 4.831 | 6.733 | 6.037 | 13.212 | 13.260 |
| Gross Profit/Loss - EUR | 11.515 | 22.228 | 18.841 | 407.923 | 7.063 | 11.437 | 9.969 | 10.761 | 4.703 | 6.545 |
| Net Profit/Loss - EUR | 9.898 | 18.672 | 15.604 | 401.622 | 6.643 | 10.950 | 9.504 | 10.267 | 4.545 | 6.357 |
| Employees | 6 | 5 | 5 | 3 | 1 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Viasanmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 47.128 | 45.201 | 49.218 | 47.394 | 44.741 | 40.639 | 38.655 | 37.261 | 35.638 | 33.990 |
| Current Assets | 156.687 | 128.039 | 151.126 | 12.323 | 20.948 | 32.687 | 192 | 18.657 | 7.627 | 8.475 |
| Inventories | 43.793 | 40.581 | 43.125 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 19.803 | 8.152 | 25.133 | 4.407 | 914 | 896 | 0 | 8.645 | 995 | 989 |
| Cash | 93.090 | 79.305 | 82.868 | 7.916 | 20.035 | 31.790 | 192 | 10.012 | 6.632 | 7.486 |
| Shareholders Funds | 157.021 | 18.939 | 22.070 | 23.588 | 29.775 | 38.582 | 37.797 | 16.263 | 13.024 | 11.430 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 46.793 | 154.301 | 178.274 | 36.129 | 35.915 | 34.743 | 1.051 | 39.654 | 30.241 | 31.035 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Viasanmed Srl